Low levels of monoclonal small B cells in the bone marrow of patients with diffuse large B-cell lymphoma of activated B-cell type but not of germinal center B-cell type

Haematologica

Volumn 95, Issue 8, 2010, Pages 1334-1341

  Tierens, Anne M ^a   Holte, Harald ^a   Warsame, Abdirashid ^a   Ikonomou, Ida M ^a   Wang, Junbai ^a   Chan, Wing C ^b   Delabie, Jan ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

B cell; Lymphocytosis; Lymphoma

Indexed keywords

CD20 ANTIGEN; CD22 ANTIGEN; CD23 ANTIGEN; CD24 ANTIGEN; CD5 ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BONE MARROW; BONE MARROW BIOPSY; CELL EXPANSION; CELL STRUCTURE; CELL TYPE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT; GERMINAL CENTER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; ANTIGENS, CD20; B-LYMPHOCYTES; BASE SEQUENCE; BONE MARROW CELLS; CLONE CELLS; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT; GERMINAL CENTER; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOPHENOTYPING; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77956026713     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.014100     Document Type: Article

References (27)

1. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (Eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC: Lyon 2008.
2. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002; 346(25):1937-47.
3. Lenz G, Wright GW, Emre NC, Kohlhammer H, Dave SS, Davis RE, et al. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways. Proc Natl Acad Sci USA. 2008; 105(36):13520-5.
4. Riemersma SA, Jordanova ES, Schop RF, Philippo K, Looijenga LH, Schuuring E, et al. Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites. Blood. 2000;96(10):3569-77.
5. Camilleri-Broët S, Crinière E, Broët P, Delwail V, Mokhtari K, Moreau A, et al. A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood. 2006;107(1):190-6.
6. Booman M, Douwes J, Glas AM, de Jong D, Schuuring E, Kluin PM. Primary testicular diffuse large B-cell lymphomas have activated B-cell-like subtype characteristics. J Pathol. 2006;210(2):163-71.
7. Hoefnagel JJ, Dijkman R, Basso K, Jansen PM, Hallermann C, Willemze R, et al. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. Blood. 2005;105(9):3671-8.
8. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res. 1971;31(11): 1860-1.
9. The International Non-Hodgkin's Lymphoma Prognostic Factors Project (no authors listed). A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993;329:987-94.
10. Hans CP, Weisenburger DD, Greiner TC, ascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103(1):275-82.
11. Sánchez ML, Almeida J, Vidriales B, Lopez-Berges MC, Garcia-Marcos MA, Moro MJ, et al. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Leukemia. 2002;16(8):1460-9.
12. Rothe G, Schmitz G. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis. Leukemia. 1996;10(5):877-95.
13. Nieto WG, Almeida J, Romero A, Teodosio C, Lopez A, Henriques AF, Sanchez ML, et al. Increased frequency (12%) of circulating chronic lymphocytic leukaemia-like B-cell clones in healthy subjects using a highly senstitive multicolour flow cytometry approach. Blood. 2009;114(1):33-7.
14. Marti GE, Rawstron AC, Ghia P, Hillmen P, Houlston RS, Kay N, et al. The International Familial CLL Consortium. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol. 2005;130(3): 325-32.
15. van Dongen JJ, Langerak AW, Brüggemann M, Evans PA, Hummel M, Lavender FL, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 ConcertedAction BMH4-CT98-3936. Leukemia. 2003;17(12):2257-317.
16. Tbakhi A, Totos G, Pettay JD, Myles J, Tubbs RR. The effect of fixation on detection of B-cell clonality by polymerase chain reaction. Mod Pathol. 1999;12(3):272-8.
17. Hanson CA, Kurtin PJ, Katzmann JA, Hoyer JD, Li C-Y, Hodnefield JM, et al. Immunophenotypic analysis of peripheral blood and bone marrow in the staging of Bcell malignant lymphoma. Blood. 1999; 94(11):3889-96.
18. Stacchini A, Demurtas A, Godia L, Martine G, Antinoro V, Palestro G. Flow cytometryin the bone marrow staging of mature Bcell neoplasms. Cytometry Part B (Clin.Cytometry). 2003;54(1):10-8.
19. Gomyo H, Shimoyama M, Minagawa K, Yakushuin K, Urahama N, Okamura A, et al. Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B-cell lymphoma. Haematologica. 2003;88(12):1358-65.
20. Rawstron AC, Green MJ, Kuzmicki A, Kennedy B, Fenton JA, Evans PA, et al. Monoclonal B lymphocytes with the characteristics of indolent chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood. 2002;100(2):635-9.
21. Ghia P, Prato G, Scielzo C, Stella S, Geuna M, Guida G, et al. Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood. 2004;103(6):2337-42.
22. Rawstron AC, Bennett FL, O'Connor SJ, Kwok M, Fenton JA, Plummer M, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med. 2008;359(6):575-83.
23. Landgren O, Albitar M, Ma W, Abbasi F, Hayes RB, Ghia P, Marti GE, Caporaso NE. B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med. 2009;360(7):659-67.
24. Kremer M, Spitzer M, Mandl-Weber S, Stecker K, Schmidt B, Hoefler H, Quintanilla-Martinez L, Fend F. Discordant bone marrow involvement in diffuse large B cell lymphoma: comparative molecular analysis reveals a heterogeneous group of disorders. Lab Invest. 2003;83(1):107-14.
25. Kluin PM, van Krieken JH, Kleiverda K, Kluin-Nelemans HC. Discordant morphologic characteristics of B-cell lymphomas in bone marrow and lymph node biopsies. Am J Clin Pathol. 1990;94(1):59-66.
26. Robertson LE, Redman JR, Butler JJ, Osborne BM, Velasquez WS, McLaughlin P, et al. Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse. J Clin Oncol. 1991;9(2):236-42.
27. Hodges GF, Lenhardt TM, Cotelingam JD. Bone marrow involvement in large-cell lymphoma. Prognostic implications of discordant disease. Am J Clin Pathol. 1994; 101(3):305-11.